New and Upcoming Treatments for Polycystic Kidney Disease.

By admin

Published: September 24, 2009

photo credit: euthman
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disease of the kidney. For many years the treatment of this condition has been at a relative standstill when compared to the advances in therapy in other kidney diseases. However exciting new developments are currently in the research pipeline. These may [...]

Rituximab and FSGS.

By admin

Published: August 31, 2009

FSGS or focal and segmental glomerulosclerosis is the most common non diabetic cause of nephrotic syndrome in the world. This is particularly true among African Americans. The treatment of this disorder is frequently complicated by non response to the primary modality of treatment which is steroids. Combine this with the need for high doses to [...]

New Drugs: Pirfenidone a new hope in diabetic kidney disease.

By admin

Published: August 19, 2009

Diabetic nephropathy may be slowed by several means, the standard of care is blood pressure control, prescription of drugs which reduce protein in the urine and dietary changes. However the condition is almost always progressive despite these interventions.
Pirfenidone is not a particularly new drug, it has been known as an antifibrotic agent in that it [...]